ARYA Sciences Acquisition Corp IV (ARYD) News Today

$11.35
+0.04 (+0.35%)
(As of 04/23/2024 ET)
SourceHeadline
marketbeat.com logoShort Interest in ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD) Drops By 87.5%
marketbeat.com - April 10 at 10:24 AM
marketbeat.com logoARYA Sciences Acquisition Corp IV (NASDAQ:ARYD) Sees Significant Increase in Short Interest
marketbeat.com - March 31 at 9:10 PM
marketbeat.com logoARYA Sciences Acquisition Corp IV (NASDAQ:ARYD) Sees Large Decline in Short Interest
marketbeat.com - March 12 at 10:39 AM
msn.com logoAdagio Medical to go public in $113M deal with SPAC ARYA Sciences
msn.com - February 14 at 10:27 AM
finance.yahoo.com logoAdagio Medical To List on Nasdaq Through Business Combination with ARYA Sciences Acquisition Corp IV, Enabling Further Commercial and Clinical Development of Innovative Cardiac Ablation Technologies
finance.yahoo.com - February 14 at 10:27 AM
prnewswire.com logoAdagio Medical To List on Nasdaq Through Business Combination with ARYA Sciences Acquisition Corp IV, Enabling Further Commercial and Clinical Development of Innovative Cardiac Ablation Technologies
prnewswire.com - February 14 at 6:06 AM
marketbeat.com logoWestchester Capital Management LLC Trims Holdings in ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD)
marketbeat.com - February 6 at 2:29 PM
marketwatch.com logo8-K: ARYA Sciences Acquisition Corp IV
marketwatch.com - April 7 at 9:11 PM
marketbeat.com logoWestchester Capital Management LLC Acquires New Shares in ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD)
marketbeat.com - March 15 at 7:43 AM
marketbeat.com logoFir Tree Capital Management LP Buys Shares of 33,784 ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD)
marketbeat.com - March 3 at 9:37 AM
benzinga.com logoARYA Sciences Acquisition Corp IV and Amicus Therapeutics, Inc. Mutually Agree to Terminate Business Combination Agreement With Respect to the Acquisition of Amicus' Gene Therapy Business Due to Market Conditions
benzinga.com - February 24 at 8:08 AM
finance.yahoo.com logoMoore Kuehn Encourages KOR, DISCA, FTSI, and ARYD Investors to Contact Law Firm
finance.yahoo.com - November 30 at 9:43 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Rigrodsky Law, P.A. Reminds Investors of Investigation of EJF, HTPA, ARYD, and ADER Mergers
finance.yahoo.com - November 9 at 8:38 PM
finance.yahoo.com logoMoore Kuehn Encourages NOTV, ARYD, XLRN, and TGP Investors to Contact Law Firm
finance.yahoo.com - October 6 at 11:13 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of ARYA Sciences Acquisition Corp. IV Merger
finance.yahoo.com - October 1 at 1:08 PM
entrepreneur.com logoAmcius (FOLD) to Spin-Off Gene Therapy Arm, Form New Firm With ARYA
entrepreneur.com - September 30 at 5:06 PM
msn.com logoAmicus Therapeutics Stock Rises; Sells Unit Stake in SPAC Deal
msn.com - September 30 at 12:05 PM
finance.yahoo.com logoAmicus stock is up 5%, the day after announcing plans to sell its gene therapy business
finance.yahoo.com - September 30 at 12:05 PM
finance.yahoo.com logoSHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of ARYA Sciences Acquisition Corp IV (Nasdaq - ARYD)
finance.yahoo.com - September 29 at 9:03 PM
feeds.benzinga.com logoPerceptive Advisors-Backed SPAC To Acquire Amicus's Gene Therapy Business
feeds.benzinga.com - September 29 at 9:47 AM
apnews.com logoAmicus Therapeutics and ARYA Sciences Acquisition Corp IV Announce Formation of a ...
apnews.com - September 29 at 6:49 AM
finance.yahoo.com logoAmicus Therapeutics and ARYA Sciences Acquisition Corp IV Announce Formation of a Next-Generation Genetic Medicine Company: “Caritas Therapeutics”
finance.yahoo.com - September 29 at 6:49 AM
Get ARYA Sciences Acquisition Corp IV News Delivered to You Automatically

Sign up to receive the latest news and ratings for ARYD and its competitors with MarketBeat's FREE daily newsletter.

This Apple-like Innovator is Revolutionizing Healthcare (Ad)

AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.

Click here to learn more about the booming eHealth industry

ARYD Media Mentions By Week

ARYD Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ARYD
News Sentiment

0.00

0.44

Average
Medical
News Sentiment

ARYD News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ARYD Articles
This Week

0

0

ARYD Articles
Average Week

Get ARYA Sciences Acquisition Corp IV News Delivered to You Automatically

Sign up to receive the latest news and ratings for ARYD and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:ARYD) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners